CHINA PHARMA HOLDINGS, INC. Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) of $22.71 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-14.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossBeforeCumulativeEffectOfChangeInAccountingPrinciple · last filed 2012-03-14
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for the quarter ending 2011-12-31 was $6.96M, a 6.61% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for the quarter ending 2011-09-30 was $3.84M, a 41.77% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for the quarter ending 2011-06-30 was $5.96M, a 11.30% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for the quarter ending 2011-03-31 was $5.96M.
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for fiscal 2011 was $22.71M, a 12.98% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. income (loss) before cumulative effect of change in accounting principle (deprecated 2011-01-31) for fiscal 2010 was $26.10M.
| Period end | Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) 3 month | Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) 6 month | Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) 9 month | Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $10.80M derived: sum of 2 quarters · filed 2012-03-14 | $16.75M derived: sum of 3 quarters · filed 2012-03-14 | $22.71M 10-K · filed 2012-03-14 |
| 2011-09-30 | $3.84M 10-Q · filed 2011-11-10 | $9.79M derived: sum of 2 quarters · filed 2011-11-10 | $15.75M 10-Q · filed 2011-11-10 | $23.20M derived: sum of 4 quarters · filed 2012-03-14 |
| 2011-06-30 | $5.96M 10-Q/A · filed 2011-09-06 | $11.91M 10-Q/A · filed 2011-09-06 | $19.37M derived: sum of 3 quarters · filed 2012-03-14 | $25.96M derived: sum of 4 quarters · filed 2012-03-14 |
| 2011-03-31 | $5.96M derived: 10-K 12 month − 3 quarters · filed 2012-03-14 | $13.41M derived: sum of 2 quarters · filed 2012-03-14 | $20.00M derived: sum of 3 quarters · filed 2012-03-14 | $26.72M derived: sum of 4 quarters · filed 2012-03-14 |
| 2010-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $14.04M derived: sum of 2 quarters · filed 2012-03-14 | $20.76M derived: sum of 3 quarters · filed 2012-03-14 | $26.10M 10-K · filed 2012-03-14 |
| 2010-09-30 | $6.59M 10-Q · filed 2011-11-10 | $13.31M derived: sum of 2 quarters · filed 2011-11-10 | $18.65M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $6.72M 10-Q/A · filed 2011-09-06 | $12.06M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |